Sofituzumab vedotin

Sofituzumab vedotin (DMUC5754A) is an MMAE-containing anti-MUC16 antibody-drug conjugate (ADC) with a protease-cleavable linker. Sofituzumab vedotin is used in cancer research.
Supplier Alfa Cytology
Product # PC0136
Pricing 1 mg, 5 mg, inquire
Feedback